Supplementary Figure S1 from Circulating Tumor DNA Dynamics Reveal <i>KRAS G12C</i> Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1078-0432.26926612